Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003.
Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003.
复制标题
美国的心理健康。
DOI：
--
复制
发表时间：
2005
期刊：
影响因子：
--
通讯作者：
M. Marlier
中科院分区：
文献类型：
--
作者：
M. Fauconnier;R. Welti;E. Blée;M. Marlier
注意力缺陷/多动障碍（ADHD），以前被称为注意力缺陷障碍，是一种神经行为障碍，其特征在于广泛的注意力不集中和多动-冲动，通常导致实质性的功能障碍。在社区样本中，学龄儿童ADHD的患病率估计为2%至18%。虽然兴奋剂药物是ADHD的有效一线治疗方法，但人们仍然担心与兴奋剂消费相关的可能副作用和长期健康结果。估计患有ADHD的儿童人数，目前正在服用药物治疗这种疾病，这是了解美国ADHD总体负担的重要一步。以前，基于人口的ADHD药物治疗的估计是不可用的，或者由于缺乏普遍性而受到限制。为了估计父母报告的ADHD诊断率和ADHD的药物治疗率，CDC分析了2003年全国儿童健康调查（NSCH）的数据。该报告描述了该分析的结果，该结果表明，在2003年，据报道约有440万4-17岁的儿童有ADHD诊断史;其中，250万（56%）据报道正在服用药物治疗该疾病。由于ADHD的药物治疗可能会带来大量的健康风险和益处，因此需要对ADHD儿童人群进行进一步研究。
Attention-deficit/hyperactivity disorder (ADHD), previously known as attention deficit disorder, is a neurobehavioral disorder characterized by pervasive inattention and hyperactivity-impulsivity that often results in substantial functional impairment. Prevalence estimates of ADHD in school-aged children have ranged from 2% to 18% in community samples. Although stimulant medications are an effective first-line treatment for ADHD , concern persists regarding the possible side effects and long-term health outcomes associated with stimulant consumption. Estimating the number of children who have had ADHD diagnosed and are currently taking medication for the disorder is an important step toward understanding the overall burden of ADHD in the United States. Previously, population-based estimates of medication treatment for ADHD were not available or were limited by their lack of generalizability. To estimate rates of parent-reported ADHD diagnosis and medication treatment for ADHD, CDC analyzed data from the 2003 National Survey of Children's Health (NSCH). This report describes the results of that analysis, which indicated that, in 2003, approximately 4.4 million children aged 4-17 years were reported to have a history of ADHD diagnosis; of these, 2.5 million (56%) were reported to be taking medication for the disorder. Because both substantial health risks and benefits might be associated with medication treatment for ADHD, further study of this population of children with ADHD is needed.